FEBRUARY 14th 2019, THURSDAY
|
| 07.30 – 08.30 |
REGISTRATION |
| |
|
| 08.30 – 09.00 |
OPENING |
| |
|
| 09.00 – 11.00 |
| IMMUNOLOGY AND IMMUNOPATOGENESIS OF MULTIPLE SCLEROSIS |
| Moderators: Dr. Ceyla İrkeç, Dr. Egemen İdiman |
| ● |
T cells in multiple sclerosis |
| |
Dr. Mayda Gürsel |
| |
|
| ● |
B cells in multiple sclerosis |
| |
Dr. Güher Saruhan Direskeneli |
| |
|
| ● |
Blood brain barrier in multiple sclerosis |
| |
Dr. Yokhutkhon Madzhidova |
| |
|
| ● |
Neuroinflammation in the immunopathogenesis of multiple sclerosis |
| |
Dr. Egemen İdiman |
| |
|
| ● |
Neurodegeneration in the immunopathogenesis of multiple sclerosis |
| |
Dr. Canan Yücesan |
|
| |
|
| 11.00 – 11.30 |
COFFEE BREAK |
| |
|
| 11.30 – 12.30 |
SATELLITE SYMPOSIUM |
| |
 |
| |
| The role and treatment options of B and T cells in the pathophysiology of multiple sclerosis |
| Moderator: Dr. Şeref Demirkaya |
| Lecturer: Dr. Firdevs Gülşen Akman |
|
| |
|
| 12.30 – 14.00 |
LUNCH |
| |
|
| 14.00 – 15.00 |
| RISK FACTORS IN MULTIPLE SCLEROSIS |
| Moderators: Dr. Hüsnü Efendi, Dr. Saltanat Kamenova |
| ● |
Genetic basis of multiple sclerosis |
| |
Dr. Mefkure Eraksoy |
| |
|
| ● |
EBV and vitamin D |
| |
Dr. Sibel Canbaz Kabay |
| |
|
| ● |
Smoking, salt, obesity |
| |
Dr. Haluk Gümüş |
|
| |
|
| 15.00 – 16.00 |
| CLINIC AND DIAGNOSIS OF MULTIPLE SCLEROSIS |
Moderators: Dr. Ömer Faruk Turan, Dr. Elkhan Muradov
|
| ● |
Clinical findings in multiple sclerosis |
| |
Dr. Münire Kılınç Toprak |
| |
|
| ● |
What did McDonald-2017 criteria bring? |
| |
Dr. Hüsnü Efendi |
| |
|
| ● |
RIS and diagnostic criteria |
| |
Dr. Serpil Demirci |
| |
|
| ● |
The clinic and diagnosis of multiple sclerosis and white matter disease in pediatric age group |
| |
Dr. Sebahattin Vurucu |
|
| |
|
| 16.00 – 16.30 |
COFFEE BREAK
|
| |
|
| 16.30 – 18.30 |
| THE LABORATORY IN MULTIPLE SCLEROSIS |
| Moderators: Dr. Murat Terzi, Dr. Bakhtior Gafurov |
| ● |
MR in the diagnosis of multiple sclerosis |
| |
Dr. Nur Yüceyar |
| |
|
| ● |
Myelocortical Multiple Sclerosis, central vein sign in multiple sclerosis |
| |
Dr. Ufuk Ergun |
| |
|
| ● |
Cerebrospinal fluid in multiple sclerosis |
| |
Dr. Murat Terzi |
| |
|
| ● |
Evoked potentials in multiple sclerosis |
| |
Dr. Nefati Kıyılıoğlu |
| |
|
| ● |
OCT and OCTA in multiple sclerosis |
| |
Dr. Fethi İdiman |
|
| |
|
FEBRUARY 15th 2019, FRIDAY
|
| 09.00 – 10.30 |
| BIOMARKERS AND MICROBIOTA IN MULTIPLE SCLEROSIS |
| Moderators: Dr. Mehmet Ufuk Aluçlu, Dr. Şirin Güven |
| ● |
Biomarkers in blood |
| |
Dr. Birsen Can Demirdöğen |
| |
|
| ● |
Biological markers of multiple sclerosis activity and progression |
| |
Dr. Alima Khamidulla |
| |
|
| ● |
Intestinal microbiota |
| |
Dr. Ayşegül Gözen |
| |
|
| ● |
Where are we in multiple sclerosis and fecal transplantation? |
| |
Dr. Ahmet Uygun |
|
| |
|
| 10.30 – 11.00 |
COFFEE BREAK
|
| |
|
| 11.00 – 12.00 |
SATELLITE SYMPOSIUM |
| |
 |
| |
B CELLS AND OCRELIZUMAB IN MULTIPLE SCLEROSIS
|
| Moderator: Dr. Ömer Faruk Turan |
| Lecturers: Dr. Sibel Canbaz Kabay, Dr. Serhan Sevim |
|
| |
|
| 12.00 – 13.00 |
LUNCH |
| |
|
| 13.00- 15.00 |
| MULTIPLE SCLEROSIS TREATMENT AND TREATMENT ROAD MAP |
| Moderators: Dr. Cavit Boz, Dr. Gulnara Rakhimbaeva |
| ● |
INF-GA |
| |
Dr. Serpil Bulut |
| |
|
| ● |
Oral treatments |
| |
Dr. Ömer Faruk Turan |
| |
|
| ● |
Treatment of attacks |
| |
Dr. Levent Sinan Bir |
| |
|
| ● |
Monoclonal antibodies |
| |
Dr. Cavit Boz |
| |
|
| ● |
Stem cell therapy in multiple sclerosis |
| |
Dr. Gülşen Akman |
|
| |
|
| 15.00- 15.30 |
COFFEE BREAK
|
| |
|
| 15.30 – 16.30 |
SATELLITE SYMPOSIUM |
| |
 |
| |
| LONG-TERM EXPERIENCE AND ACTUAL REAL LIFE DATA WITH FINGYA |
Moderator: Dr. Şeref Demirkaya
|
| ● |
What did the long-term with Fingya teach us? |
| |
Dr. Şeref Demirkaya |
| |
|
| ● |
Real Life Data in the World and Turkey |
| |
Dr. Murat Terzi |
|
| |
|
| 16.30- 18.00 |
| TREATMENT IN SPECIAL SITUATIONS |
| Moderators: Dr. Aysun Ünal, Dr. Yokhutkhon Madzhidova |
| ● |
Treatment of patients with high activity in early period |
| |
Dr. Taşkın Duman |
| |
|
| ● |
Determinants of treatment choice and change |
| |
Dr. Murat Terzi |
| |
|
| ● |
Diagnosis and treatment of PML and other opportunistic infections |
| |
Dr. Aslı Tuncer |
| |
|
| ● |
The natural course of multiple sclerosis and the risk of malignancy in the treatment of multiple sclerosis |
| |
Dr. Uğur Uygunoğlu |
| |
|
| ● |
Treatment in pediatric multiple sclerosis |
| |
Dr. Sohanvar Shomansurov |
|
| |
|
| 18.00 – 19.00 |
| SYMPTOMATIC THERAPY IN MULTIPLE SCLEROSIS |
| Moderators: Dr. Cemal Özcan, Dr. Aynur Feyzioğlu |
| ● |
Treatment of fatigue, bladder and intestinal problems |
| |
Dr. Gencer Genç |
| |
|
| ● |
Cognitive dysfunction and its treatment |
| |
Dr. Zarif Ibodullaev |
| |
|
| ● |
Depression and its treatment |
| |
Dr. Matlyuba Sanoyeva |
| |
|
| ● |
Treatment of spasticity and tremor |
| |
Dr. Muammer Korkmaz |
|
| |
FEBRUARY 16th 2019, SATURDAY
|
| 09.00 – 11.00 |
| PREGNANCY AND SPECIAL CONDITIONS IN MULTIPLE SCLEROSIS |
| Moderators: Dr. Alev Leventoğlu, Dr. Mastura Negmatullaeva |
| ● |
Treatment of attacks during pregnancy and lactation |
| |
Dr. Belgin Petek Balcı |
| |
|
| ● |
Symptomatic treatment during pregnancy and lactation |
| |
Dr. Belgin Koçer |
| |
|
| ● |
Vaccination, assisted reproductive interventions and childbirth in multiple sclerosis |
| |
Dr. Demet Yandım Kuşcu |
| |
|
| ● |
Nutrition and exercise |
| |
Dr. Özlem Taşkapılıoğlu |
|
| |
|
| 11.00 – 11.30 |
COFFEE BREAK
|
| |
|
| 11.30 – 12.30 |
UYDU SEMPOZYUM |
| |
 |
| DYMETHYL FUMARAT IN MULTIPLE SCLEROSIS AND CURRENT DATA |
| Moderator: Dr. Şeref Demirkaya |
| Lecturer: Dr. Ömer Faruk Turan |
|
| |
|
| 12.30 – 14.00 |
LUNCH |
| |
|
| 14.00 – 15.30 |
| MULTIPLE SCLEROSIS PHENOTYPE AND PREVALANCE BY COUNTRIES |
| Moderators: Dr. Bijen Nazlıel, Dr. Anara Toktomametova |
| ● |
Turkey |
| |
Dr. Erdem Toğrul |
| |
|
| ● |
Kazakhstan |
| |
Features of multiple sclerosis in Kazakhstan |
| |
Dr. Gulsum Duschanova |
| |
|
| ● |
Kirghizistan |
| |
Dr. Nurjan Djaparaliyeva |
| |
|
| ● |
Azerbaijan |
| |
Dr. Elkhan Muradov |
| |
|
| ● |
Uzbekistan |
| |
Dr. Bakhtior Gafurov |
| |
|
| ● |
Turkish Republic of Northern Cyprus |
| |
Dr. Sıla Usar |
|
| |
|
| 15.30 – 16.00 |
ARA |
| |
|
| 16.00 – 18.30 |
| MULTIPLE SCLEROSIS DIAGNOSIS AND TREATMENT APPLICATIONS ACCORDING TO COUNTRIES; WHAT CAN WE DO IN THE FUTURE? |
| Moderators: Dr. Şeref Demirkaya, Dr. Sıla Usar |
| ● |
Kazakhstan |
| |
Diagnosis and treatment of Multiple Sclerosis in Kazakhstan |
| |
Dr. Saltanat Kamenova, Dr. A. Sharapkhanova |
| |
|
| ● |
Kırghizistan |
| |
Dr. Kunduz Karbozova |
| |
|
| ● |
Azerbaijan |
| |
Dr. Elkhan Muradov |
| |
|
| ● |
Uzbekistan |
| |
Dr. Gulnara Rakhimbaeva |
| |
|
| ● |
Turkish Republic of Northern Cyprus |
| |
Dr. Sıla Usar |
| |
|
| ● |
Turkey |
| |
Dr. Şeref Demirkaya |
|
| |
|
FEBRUARY 17th 2019, SUNDAY
|
| 09.00 – 10.00 |
| NEUROMYELITIS OPTICA (NMO) |
Moderators: Dr. Dilcan Kotan Dündar, Dr. Gulnar Kabdrakhmanova
|
| ● |
Classification and pathogenesis of neuromyelitis optica spectrum diseases and AQP4-Ab positive / negative diseases |
| |
Dr. Münife Neyal |
| |
|
| ● |
Clinic and diagnosis of neuromyelitis optica |
| |
Dr Gulnara Rakhimbaeva |
| |
|
| ● |
Treatment of neuromyelitis optica |
| |
Dr. Serhan Sevim |
|
| |
|
| 10.00 – 10.30 |
| RATIONAL DRUG USE IN MULTIPLE SCLEROSIS |
Moderators: Dr. Semra Mungan, Dr. Nedime Tuğçe Bilbay
|
| ● |
Dr. Tahir Kurtuluş Yoldaş |
|
| |
|
| 10.30 – 11.00 |
COFFEE BREAK
|
| |
|
| 11.00 – 12.30 |
ORAL PRESENTATIONS |
| |
Moderators: Dr. Belgin Koçer, Dr. Zarema Kadırova, Gulnar Kabdrakhmanova
|
| |
|
| 12.30 – 13.00 |
CLOSING |
| |
|
| |
|
